Entheon Biomedical Corp. (CSE:ENBI)

Entheon Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Cash & Equivalents	0.38	0.14	0.34	0.68	2.05	2.79
Trading Asset Securities	-	-	-	-	-	0.05
Cash & Short-Term Investments	0.38	0.14	0.34	0.68	2.05	2.84
Cash Growth	67.20%	-60.39%	-49.33%	-66.81%	-27.77%	2418.31%
Other Receivables	0.01	0	0.01	0.04	0.03	0.08
Receivables	0.01	0	0.01	0.04	0.03	0.08
Inventory	-	-	-	-	0.03	-
Prepaid Expenses	0.01	0.04	0.05	0.02	1.1	1.49
Total Current Assets	0.4	0.18	0.4	0.74	3.21	4.4
Property, Plant & Equipment	-	-	-	-	0.16	0.01
Long-Term Investments	-	-	-	-	0.7	0.06
Other Intangible Assets	-	-	-	-	5.9	-
Other Long-Term Assets	0.01	0.01	0.01	0.03	-	-
Total Assets	0.41	0.19	0.4	0.77	9.98	4.47
Accounts Payable	0.02	0.04	0.08	0.14	0.93	0.72
Accrued Expenses	0	0	0	0.02	-	0
Total Current Liabilities	0.02	0.04	0.09	0.15	0.93	0.73
Total Liabilities	0.02	0.04	0.09	0.15	0.93	0.73
Common Stock	20.61	20.11	19.96	19.35	19.35	7.15
Retained Earnings	-20.95	-20.92	-21.31	-21.61	-13.55	-4.66
Comprehensive Income & Other	0.73	0.96	1.66	2.87	3.24	1.26
Shareholders' Equity	0.39	0.15	0.32	0.61	9.05	3.74
Total Liabilities & Equity	0.41	0.19	0.4	0.77	9.98	4.47
Net Cash (Debt)	0.38	0.14	0.34	0.68	2.05	2.84
Net Cash Growth	67.20%	-60.39%	-49.33%	-66.81%	-27.77%	2487.89%
Net Cash Per Share	0.03	0.02	0.06	0.12	0.38	1.03
Filing Date Shares Outstanding	13.86	8.86	5.91	5.91	5.91	4.04
Total Common Shares Outstanding	13.86	8.86	5.91	5.91	5.91	4.04
Working Capital	0.38	0.14	0.31	0.59	2.28	3.68
Book Value Per Share	0.03	0.02	0.05	0.10	1.53	0.93
Tangible Book Value	0.39	0.15	0.32	0.61	3.15	3.74
Tangible Book Value Per Share	0.03	0.02	0.05	0.10	0.53	0.93
Machinery	-	-	-	-	0.16	0.01
Leasehold Improvements	-	-	-	-	0.04	-

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.